Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
Author:
Affiliation:
1. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
2. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden/Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Abstract
Funder
vetenskapsrådet
Hjärnfonden
Publisher
SAGE Publications
Subject
Neurology (clinical),Neurology
Link
http://journals.sagepub.com/doi/pdf/10.1177/13524585211026272
Reference21 articles.
1. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
2. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
3. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
4. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments
5. The Swedish MS registry – clinical support tool and scientific resource
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022;Multiple Sclerosis Journal;2024-01-21
2. Two cases of nasopharyngeal negative COVID-19 infections in patients with demyelinating diseases on anti-CD20 treatments;Neuroimmunology Reports;2024
3. Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption;Frontiers in Immunology;2023-07-27
4. Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis;JAMA Network Open;2023-06-23
5. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes;Multiple Sclerosis and Related Disorders;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3